In this respect, a recent study investigating the relative effect of IL-2 and IL-15 in in vitro treatment described a better persistence of IL-15 effects on NK cells anti-tumor functions upon cytokine withdrawal [21]. The gene discussed is IL2; the disease is neoplasm.